farnesyl acetate,
farnesylacetate,
farnesylacetic acid,
farnesylacetic acid, (E,E)-isomer,
Farnesyl acetate,
Farnesol acetate,
29548-30-9,
All-trans-Farnesyl acetate,
UNII-D5ZJ1FOC2I,
trans,trans-Farnesyl acetate,
D5ZJ1FOC2I,
4128-17-0,
3,7,11-Trimethyl-2,6,10-dodecatrienyl acetate,
(2E,6E)-Farnesyl acetate,
ZGIGZINMAOQWLX-NCZFFCEISA-N,
2,6,10-Dodecatrien-1-ol, 3,7,11-trimethyl-, acetate, (E,E)-,
MFCD00036516,
[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl] acetate,
J-500791,
(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl acetate,
farneoylacetate,
trans2,trans6-Farnesyl acetate,
Farnesyl acetate, (2E,6E)-,
WE(17:3),
E,E-Farnesyl Acetate,
(E)-Farnesyl acetate,
(E,E)-farnesyl acetate,
AC1LCWI8,
AC1Q65TN,
DSSTox_CID_27110,
DSSTox_RID_82120,
Farnesyl acetate, (E,E)-,
DSSTox_GSID_47110,
(cis,trans)-Farnesyl acetate,
trans, trans-Farnesyl acetate,
CHEMBL3184169,
DTXSID5047110,
farnesyl acetate, No Antioxidant,
(2E,6E)-3,7,11-Trimethyl-2,6,10-dodecatrienyl acetate,
2-trans-6-trans-Farnesyl acetate,
trans-2-trans-6-Farnesyl acetate,
trans,trans-Farnesyl acetate, 95%,
ZINC1719908,
Farnesyl acetate, mixture of isomers,
Tox21_302688,
LMFA07010230,
NSC132958,
AKOS025295075,
NSC-132958,
ACM29548309,
NCGC00256905-01,
CAS-4128-17-0,
TR-012831,
3,11-Trimethyl-2,6,10-dodecatrienyl acetate,
Farnesyl acetate, technical, mixture of isomers,
A819958,
Farnesyl acetate, 95%, mixture of cis and trans,
S14-1289,
2,10-Dodecatrien-1-ol, 3,7,11-trimethyl-, acetate,
UNII-2ARF3ZNJ1R component ZGIGZINMAOQWLX-NCZFFCEISA-N,
(2E,6Z)-1-Acetoxy-3,7,11-trimethyl-2,6,10-dodecatriene,
(2Z,6Z)-3,7,11-Trimethyl-2,6,10-dodecatriene-1-ol acetate,
(E,E)-3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol acetate,
(E,E)-3,7,11-Trimethyl-2,6,10-dodecatrien-1-yl acetate,
[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl] ethanoate,
Acetic acid (6E)-3,7,11-trimethyl-2,6,10-dodecatrienyl ester,
[(E,E)-3,7,11-Trimethyl-2,6,10-dodecatriene-1-yl]ester of acetic acid,
2,6,10-dodecatrien-1-ol, 3,7,11-trimethyl-, acetate, (2E,6E)-,
acetic acid [(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl] ester,
InChI=1/C17H28O2/c1-14(2)8-6-9-15(3)10-7-11-16(4)12-13-19-17(5)18/h8,10,12H,6-7,9,11,13H2,1-5H3/b15-10+,16-12,
Farnesylacetate,
UNII-2ARF3ZNJ1R,
trans,trans-Farnesol acetate,
C17H28O2,
EINECS 249-689-1,
AR-1J0728,
CID638500,
C17-H28-O2,
NSC 132958,
AI3-33837,
EC 249-689-1,
3,7,11-Trimethyldodeca-2,6,10-trienyl acetate,
2,6,10-Dodecatrien-1-ol, 3,7,11-trimethyl-, acetate,
3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol acetate,
3,7,11-Trimethyl-2,6,10-dodecatrien-1-yl acetate,
3,7,11 - trimethyldodeca - 2,6,10 - trienyl acetate,
3, 7, 11- trimethyldodeca- 2, 6, 10- trienyl acetate,
2,6,10-Dodecatrien-1-ol, 3,7,11-trimethyl-, acetate (E,E)-,
Farnesyl acetate, 95%, mixture of cis and trans - 100ML 100ml,
30344-96-8,
Draw
SDS
COA
Add to Cart
